On February 25, 2020 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, reported that members of the management team will participate in the following upcoming scientific and investor conferences (Press release, Pieris Pharmaceuticals, FEB 25, 2020, View Source [SID1234554702]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
6th Annual Immuno-Oncology 360° Conference
Friday, February 28, 2020 at 1:50 PM EST in New York.
Presentation Title: Enhancing Efficacy and Safety of 4-1BB Agonism with Tumor-Targeted Bispecifics
Cowen and Company 40th Annual Health Care Conference
Tuesday, March 3, 2020 at 10:40 AM EST in Boston.
A webcast of the Company’s presentation will be available at this link.